SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-10-035648
Filing Date
2010-04-16
Accepted
2010-04-16 17:22:28
Documents
9
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 INVERNESS MEDICAL INNOVATIONS, INC. b80418a2e10vkza.htm 10-K/A 3197296
2 EX-10.31 b80418a2exv10w31.htm EX-10.31 82386
3 EX-10.32 b80418a2exv10w32.htm EX-10.32 24561
4 EX-23.1 b80418a2exv23w1.htm EX-23.1 2001
5 EX-31.1 b80418a2exv31w1.htm EX-31.1 5865
6 EX-31.2 b80418a2exv31w2.htm EX-31.2 5838
7 EX-32.1 b80418a2exv32w1.htm EX-32.1 4048
8 GRAPHIC b80418a2b8041801.gif GRAPHIC 9069
9 GRAPHIC b80418a2b8041802.gif GRAPHIC 3311
  Complete submission text file 0000950123-10-035648.txt   3340804
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

IRS No.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16789 | Film No.: 10755554
SIC: 2835 In Vitro & In Vivo Diagnostic Substances